Back to Search
MARY CIANFROCCA, DO
DO
Hematology & Oncology Physician
NPI: 1821050550IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Medical Oncology
Code: 207RX0202X
005743(AZ)20A18005(CA)036086852(IL)
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
20A18005(CA)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1989
Research & Publications (12)
Overcoming recurrence risk: extended adjuvant endocrine therapy.
PMID 19073503·Clin Breast Cancer·2008
6-review
Counterpoint: the argument for combination chemotherapy in the treatment of metastatic breast cancer.
PMID 17927925·J Natl Compr Canc Netw·2007
8-other
Optimizing endocrine therapy for premenopausal and postmenopausal women with breast cancer.
PMID 17313157·Oncology (Williston Park)·2007
6-review
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours.
PMID 16705310·Br J Cancer·2006
3-trial
Prognostic and predictive factors in early-stage breast cancer.
PMID 15561805·Oncologist·2004
6-review
Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study.
PMID 11773164·J Clin Oncol·2002
3-trial
A phase I and pharmacokinetic study of lapatinib in combination with letrozole in patients with advanced cancer.
PMID 18628463·Clin Cancer Res·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1500 DUARTE RD
DUARTE, CA 91010 - Phone
- (626) 256-4673
Quick Facts
- NPI
- 1821050550
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 37
- Publications
- 12
Are you this provider?
Claim Your Profile